Calumet (CLMT) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
A corporate reorganization is proposed to convert from a master limited partnership to a corporation, involving a merger and exchange of units for shares and warrants.
The conversion aims to eliminate incentive distribution rights, broaden the investor base, and improve access to capital markets.
The transaction is subject to unitholder approval, regulatory clearance, and other customary closing conditions.
The conversion is expected to be accretive to long-term cash flow and align with market trends favoring C-corporation structures.
Voting matters and shareholder proposals
Unitholders will vote on the Conversion Agreement, Board Classification, exclusive Delaware forum provision, amended long-term incentive plan, and potential adjournment.
Approval of both the Conversion and Board Classification proposals is required to consummate the conversion.
Sponsor Parties, holding 20.4% of units, are obligated to vote in favor of the conversion.
The Board recommends voting FOR all proposals.
Board of directors and corporate governance
The new board will have 10 directors, initially designated by The Heritage Group, divided into three classes with staggered terms.
The Heritage Group retains nomination rights for up to two directors, depending on ownership percentage.
The new governance structure includes anti-takeover provisions and exclusive forum selection.
Latest events from Calumet
- Adjusted EBITDA rose 30%, net loss narrowed, and $222M debt was cut amid record specialty output.CLMT
Q4 202527 Feb 2026 - Q2 2024 delivered $66.8M EBITDA, record volumes, and C-Corp conversion amid margin pressure.CLMT
Q2 20241 Feb 2026 - Record SAF output, $1.44B DOE loan, and $150M sale-leaseback drive growth and liquidity.CLMT
Q3 202415 Jan 2026 - DOE loan enables major SAF expansion, debt reduction, and strategic growth for renewables.CLMT
Status Update10 Jan 2026 - C-Corp conversion, DOE loan, and asset sale drive deleveraging and renewables growth.CLMT
Q4 20241 Dec 2025 - Q2 2025 posted a $147.9M loss, but cost cuts and specialty gains drove operational progress.CLMT
Q2 202523 Nov 2025 - Q1 2025 net loss deepened, but EBITDA, liquidity, and SAF expansion advanced.CLMT
Q1 202520 Nov 2025 - Q3 2025 saw record EBITDA, net income, and SAF progress, with cost cuts and deleveraging.CLMT
Q3 202513 Nov 2025